Immediate Impact
24 hit
Citing Papers
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
2025 Hit
Challenges and Future Trends in the Treatment of Psoriasis
2023 Hit
Works of Helen McAteer being referenced
A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial
2018
Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment
2016
Author Peers
Peers are selected by citation overlap in the author's most active subfields. citations · hero ref
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Helen McAteer | 115 | 106 | 53 | 33 | 32 | 20 | 262 | |
| Aparna Sajja | 28 0.2× | 107 1.0× | 26 0.5× | 41 1.2× | 12 0.4× | 23 | 307 | |
| Roger S. Ho | 14 0.1× | 151 1.4× | 96 1.8× | 5 0.2× | 17 0.5× | 15 | 313 | |
| Elizabeth Faust | 31 0.3× | 35 0.3× | 17 0.3× | 4 0.1× | 22 0.7× | 21 | 316 | |
| M. Gutknecht | 68 0.6× | 105 1.0× | 157 3.0× | 1 0.0× | 27 0.8× | 22 | 319 | |
| Nina Wilson | 41 0.4× | 98 0.9× | 61 1.2× | 1 0.0× | 18 0.6× | 20 | 253 | |
| Sara Hogan | 22 0.2× | 27 0.3× | 158 3.0× | 7 0.2× | 32 1.0× | 28 | 287 | |
| John Latella | 35 0.3× | 98 0.9× | 67 1.3× | 1 0.0× | 16 0.5× | 18 | 164 | |
| Hanaa Emam | 7 0.1× | 76 0.7× | 101 1.9× | 6 0.2× | 7 0.2× | 20 | 287 | |
| James Lucas | 36 0.3× | 74 0.7× | 37 0.7× | 11 0.3× | 18 | 157 | ||
| Elisa Muscianisi | 13 0.1× | 122 1.2× | 159 3.0× | 2 0.1× | 8 0.3× | 28 | 299 |
All Works
Loading papers...